Fraunhofer Institute for Biomedical Engineering
Medical Biotechnology
Press Releases
- A new EBiSC iPSC-derived neuronal cell product simplifies neuroscience research
- A new generation of microimplants
- Fraunhofer at MEDICA/COMPAMED 2022: BioSensoLab - Biological laboratory to go
- Fraunhofer IBMT in EC-Horizon 2020 - FET Open Project GLADIATOR - New technologies for cancer monitoring and therapy: A transdisciplinary, paradigm-shifting, approach with bio-nanodevice interfaces
- Fraunhofer IBMT is part of the European Partnership for the Assessment of Risks from Chemicals (PARC)
- Fraunhofer IBMT Partner in the new EU Project “SafePolyMed” - Safer Drug Treatment and Enhanced Patient Empowerment
- EBiSC2 and FAIRplus are improving FAIRness of stem cell data
- Press Release MEDICA 2021: Biotechnology Stem cells from the bioreactor
- Press Release COMPAMED/MEDICA 2021: Miniaturized and networked active implants: Safe, patient-friendly implants for personalized therapy
- BMBF joint project Ophthalmo-AI started: Intelligent, cooperative support for diagnosis and therapy in ophthalmology
- Fraunhofer IBMT collaborates in EC project for water saving solution for textile industry: Waste2Fresh - Smart innovative system for recycling wastewater and creating closed loops in textile manufacturing industrial processes
- Strengthening the innovative power of the German medical technology industry: Advanced Systems Engineering aims to reduce production costs for SMEs and increase design flexibility: Exemplary testing on application cases from the fields of in-vitro diagnostics, medical devices and implants
- SABYDOMA - Increasing safety of nanomaterials through accurate design
- ERA-NET project on translational research on cancer: NExT – Earlier diagnosis of endocrine pancreatic tumors
- Human cell-based test systems for toxicity studies: R2U-Tox-Assay - Ready-to-use Toxicity Screening Assay based on iPS-Technologies
- European scientists in the fight against cancer: VISION - Strategies to strengthen scientific excellence and innovation in the early diagnosis of stomach and colon cancer
- NanoCELL - Nanocellulose as great hope for environmentally friendly packaging
- VISION - A microfluidic chip system as an alternative to animal experiments
- Mobile units and safety laboratories in the context of time-critical pandemic events - Strategies and concepts for productivity assurance through rapid on-site testing
- The mobile Fraunhofer IBMT epidemiological laboratory (epiLab) in use for nationwide early detection and prevention of SARS-CoV-2 infections
- New screening approach in the fight against viruses
- Fraunhofer IBMT in EC-FET Open Project GLADIATOR - New technologies for cancer monitoring
- Meet Fraunhofer IBMT at BIO International Convention, Philadelphia, USA, 2019: Stem cell applications - Application-specific high-throughput production processes revolutionize industrial new drug testing
- Fraunhofer three times in joint action - Laboratory technology and biotechnology in the mobile epidemiological BSL2 laboratory, the so-called mobile EpiLab
- EBiSC2 – The European Bank for induced pluripotent Stem Cells launches a second project phase to become a self-sustainable repository for human induced pluripotent stem cells (hiPSC), extend the existing cell catalogue, and offer additional hiPSC-related services
- Committed to Highest Quality: Laboratories of Medical Biotechnology of the Fraunhofer IBMT certified and accredited
- Fraunhofer IBMT at ACHEMA 2018 – Saarland pavilion hall 5.1D89 - Process technology, medical biotechnology, process monitoring and control – The Fraunhofer Institute for Biomedical Engineering IBMT shows new research and development
- MEDICA 2017: Laboratory in a bag - Growing human stem cells
- HISENTS: Multi-Organ Platform for Risk Assessment of Nanomaterials
- Project NanoUmwelt - Detecting Minute Nano Amounts in Environmental Samples
- Launch of the new European Stem Cell Bank - EBiSC European Bank for induced pluripotent Stem Cells
- Growing Stem Cells faster on Seaweed
- On the Track of Nanomaterials - Researchers pave the way for realistic risk assessment of nanomaterials in the environment
- Central Biobank for Drug Research